They say RFK Jr. would threaten the achievements - including combating deadly diseases and monitoring drug safety - of a science-based public health order painstakingly built since World War II.
Dr. Jianjun ZOU, General Manager and CEO of Junshi Biosciences, said, “The approval of toripalimab by MHRA marks another significant milestone for toripalimab in Europe, not onl ...